Castleark Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,010
| Closed | -$4.18M | – | 354 |
|
|
2024
Q4 | $4.18M | Sell |
50,010
-1,870
| -4% | -$156K | 0.15% | 152 |
|
|
2024
Q3 | $3.8M | Sell |
51,880
-1,900
| -4% | -$139K | 0.15% | 140 |
|
|
2024
Q2 | $3.68M | Sell |
53,780
-450
| -0.8% | -$30.8K | 0.15% | 142 |
|
|
2024
Q1 | $3.75M | Sell |
54,230
-19,570
| -27% | -$1.35M | 0.16% | 145 |
|
|
2023
Q4 | $5.29M | Sell |
73,800
-100
| -0.1% | -$7.16K | 0.23% | 104 |
|
|
2023
Q3 | $3.85M | Sell |
73,900
-3,390
| -4% | -$177K | 0.2% | 126 |
|
|
2023
Q2 | $4.89M | Buy |
77,290
+53,120
| +220% | +$3.36M | 0.22% | 108 |
|
|
2023
Q1 | $1.31M | Sell |
24,170
-37,200
| -61% | -$2.01M | 0.06% | 179 |
|
|
2022
Q4 | $3.25M | Sell |
61,370
-26,810
| -30% | -$1.42M | 0.17% | 133 |
|
|
2022
Q3 | $4.1M | Sell |
88,180
-2,000
| -2% | -$93.1K | 0.23% | 114 |
|
|
2022
Q2 | $5.15M | Buy |
90,180
+49,910
| +124% | +$2.85M | 0.28% | 94 |
|
|
2022
Q1 | $2.46M | Buy |
+40,270
| New | +$2.46M | 0.11% | 171 |
|